Financial Snapshot

Revenue
$4413B
TTM
Gross Margin
66.12%
TTM
Net Earnings
$149.9B
TTM
Current Assets
$3108B
Q2 2024
Current Liabilities
$2465B
Q2 2024
Current Ratio
126.06%
Q2 2024
Total Assets
$16230B
Q2 2024
Total Liabilities
$8429B
Q2 2024
Book Value
$7798B
Q2 2024
Cash
$804.3B
Q2 2024
P/E
45.06
Nov 29, 2024 EST
Free Cash Flow
$444.2B
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Revenue $4264B $4027B $3569B $3198B $3291B $2097B $1771B $1732B $1807B $1778B $1692B $1557B $1509B $1419B $1466B $1538B $1375B $1305B $1212B $1123B $1086B $1046B $1005B $963.5B $923.1B $844.6B $841.8B $838.8B $801.3B $771.7B $727.8B
YoY Change 5.87% 12.85% 11.61% -2.84% 56.93% 18.45% 2.22% -4.17% 1.66% 5.09% 8.63% 3.2% 6.31% -3.18% -4.7% 11.9% 5.34% 7.67% 7.95% 3.36% 3.86% 4.08% 4.32% 4.37% 9.29% 0.34% 0.36% 4.68% 3.85% 6.02%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Revenue $4264B $4027B $3569B $3198B $3291B $2097B $1771B $1732B $1807B $1778B $1692B $1557B $1509B $1419B $1466B $1538B $1375B $1305B $1212B $1123B $1086B $1046B $1005B $963.5B $923.1B $844.6B $841.8B $838.8B $801.3B $771.7B $727.8B
Cost Of Revenue $1427B $1244B $1107B $994.3B $1090B $651.7B $495.9B $558.8B $535.4B $521.0B $490.3B $447.6B $433.2B $317.6B $285.1B $289.5B $278.6B $279.7B $282.1B $279.2B $269.4B $300.3B $337.9B $384.0B $432.3B $435.8B $443.3B $449.2B $433.4B $428.1B $397.4B
Gross Profit $2837B $2783B $2462B $2204B $2201B $1445B $1275B $1173B $1272B $1257B $1201B $1110B $1076B $1102B $1181B $1249B $1096B $1026B $930.1B $843.8B $817.0B $745.7B $667.2B $579.5B $490.8B $408.9B $398.5B $389.6B $367.9B $343.5B $330.4B
Gross Profit Margin 66.54% 69.11% 68.99% 68.91% 66.89% 68.92% 71.99% 67.74% 70.38% 70.7% 71.02% 71.26% 71.29% 77.63% 80.55% 81.18% 79.73% 78.57% 76.73% 75.14% 75.2% 71.29% 66.38% 60.14% 53.17% 48.41% 47.34% 46.45% 45.91% 44.52% 45.4%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Selling, General & Admin $1054B $997.3B $886.4B $875.7B $964.7B $717.6B $628.1B $619.1B $650.8B $614.9B $561.2B $541.4B $444.0B $382.5B $464.3B $489.3B $397.3B $373.7B $357.7B $317.1B $315.8B $310.8B $285.7B $263.5B $242.1B $189.1B $201.3B $203.5B $270.8B $261.1B $254.5B
YoY Change 5.67% 12.52% 1.22% -9.23% 34.44% 14.25% 1.46% -4.87% 5.84% 9.55% 3.67% 21.93% 16.09% -17.63% -5.11% 23.16% 6.3% 4.49% 12.81% 0.41% 1.59% 8.8% 8.41% 8.85% 27.99% -6.03% -1.07% -24.87% 3.73% 2.58%
% of Gross Profit 37.14% 35.83% 36.0% 39.74% 43.82% 49.64% 49.28% 52.76% 51.16% 48.92% 46.71% 48.79% 41.27% 34.71% 39.32% 39.18% 36.24% 36.44% 38.45% 37.57% 38.65% 41.68% 42.82% 45.48% 49.33% 46.26% 50.51% 52.22% 73.61% 76.0% 77.03%
Research & Development $729.9B $633.3B $526.1B $455.8B $492.4B $368.3B $325.4B $312.3B $382.1B $341.6B $324.3B $281.9B $288.9B $296.4B $453.0B $275.8B $193.3B $169.6B $141.5B $129.7B $124.2B $100.3B $89.85B $77.26B $77.49B $79.04B $71.75B
YoY Change 15.25% 20.38% 15.41% -7.42% 33.69% 13.17% 4.21% 11.87% 5.32% 15.04% -2.42% -2.54% -34.58% 64.27% 42.67% 13.94% 19.93% 9.1% 4.36% 23.89% 11.61% 16.29% -0.29% -1.96% 10.15%
% of Gross Profit 25.73% 22.75% 21.37% 20.69% 22.37% 25.48% 25.53% 26.62% 30.4% 28.43% 29.23% 26.2% 26.22% 25.1% 36.28% 25.16% 18.85% 18.24% 16.76% 15.87% 16.66% 15.03% 15.5% 15.74% 18.95% 19.83% 18.42%
Depreciation & Amortization $728.0B $664.4B $583.2B $559.7B $583.6B $272.4B $182.1B $171.4B $197.4B $261.0B $215.7B $201.1B $150.2B $106.7B $114.8B $118.1B $31.69B $28.82B $28.73B $31.23B $28.08B $29.96B $28.43B $33.61B $33.36B $4.466B $4.033B
YoY Change 9.57% 13.93% 4.2% -4.11% 114.23% 49.59% 6.24% -13.15% -24.36% 20.95% 7.28% 33.9% 40.73% -7.06% -2.76% 272.61% 9.96% 0.32% -8.0% 11.19% -6.27% 5.39% -15.4% 0.72% 10.74%
% of Gross Profit 25.66% 23.87% 23.68% 25.4% 26.51% 18.85% 14.29% 14.61% 15.52% 20.76% 17.96% 18.12% 13.96% 9.69% 9.72% 9.46% 2.89% 2.81% 3.09% 3.7% 3.44% 4.02% 4.26% 5.8% 6.8% 1.12% 1.04%
Operating Expenses $2623B $2293B $1917B $1868B $1915B $1262B $1072B $982.0B $1125B $1168B $1050B $987.1B $810.7B $734.7B $760.7B $942.3B $673.0B $567.0B $527.3B $462.7B $445.4B $435.1B $386.0B $353.4B $319.4B $266.6B $284.8B $279.2B $270.8B $261.1B $254.5B
YoY Change 14.4% 19.63% 2.62% -2.46% 51.74% 17.75% 9.14% -12.69% -3.71% 11.28% 6.34% 21.76% 10.34% -3.41% -19.28% 40.01% 18.7% 7.53% 13.95% 3.89% 2.38% 12.72% 9.23% 10.65% 19.77% -6.37% 1.98% 3.11% 3.73% 2.58%
Operating Profit $214.1B $490.5B $545.5B $335.7B $286.5B $183.5B $202.8B $191.3B $147.2B $88.69B $151.7B $122.5B $265.0B $367.1B $420.2B $306.5B $423.1B $458.5B $402.8B $381.0B $371.6B $310.7B $281.2B $226.1B $171.4B $142.2B $113.7B $110.3B $97.11B $82.43B $75.91B
YoY Change -56.36% -10.08% 62.48% 17.18% 56.14% -9.54% 6.06% 29.96% 65.93% -41.55% 23.86% -53.78% -27.8% -12.64% 37.11% -27.57% -7.72% 13.83% 5.71% 2.53% 19.62% 10.47% 24.39% 31.88% 20.55% 25.04% 3.07% 13.64% 17.8% 8.59%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Interest Expense -$161.3B -$115.4B -$142.6B -$234.7B -$158.2B -$97.08B $42.55B -$3.401B $2.455B $2.760B $26.48B $56.42B $2.333B $9.896B $4.616B $10.12B $157.1B $139.3B $100.1B $63.20B $79.29B $98.30B $83.13B $29.87B $53.98B $43.53B $9.702B $3.525B $3.636B $5.237B $6.137B
YoY Change 39.74% -19.08% -39.23% 48.36% 62.98% -328.15% -1351.07% -238.53% -11.05% -89.58% -53.07% 2318.3% -76.42% 114.38% -54.38% -93.56% 12.8% 39.15% 58.36% -20.3% -19.33% 18.24% 178.32% -44.67% 24.03% 348.62% 175.23% -3.05% -30.57% -14.67%
% of Operating Profit -75.34% -23.53% -26.15% -69.91% -55.22% -52.91% 20.98% -1.78% 1.67% 3.11% 17.45% 46.05% 0.88% 2.7% 1.1% 3.3% 37.13% 30.37% 24.85% 16.59% 21.34% 31.64% 29.56% 13.21% 31.49% 30.6% 8.53% 3.19% 3.74% 6.35% 8.08%
Other Income/Expense, Net $1.000M $1.000M $1.000M $0.00 $0.00 -$17.03B -$286.0M -$3.200B -$14.69B $5.407B -$5.150B $4.320B -$5.485B -$2.118B -$4.843B $428.0M -$5.163B $6.233B -$2.688B -$3.603B -$198.0M -$161.0M -$1.756B -$1.555B -$690.0M
YoY Change -100.0% 5854.2% -91.06% -78.22% -371.7% -204.99% -219.21% -178.76% 158.97% -56.27% -1231.54% -108.29% -182.83% -331.88% -25.4% 1719.7% 22.98% -90.83% 12.93% 125.36%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Pretax Income $52.79B $375.1B $302.6B $366.2B -$60.75B $127.6B $217.2B $143.3B $120.5B -$145.4B $158.9B $129.7B $252.5B $371.6B $415.8B $398.5B $576.8B $625.4B $518.0B $441.1B $446.1B $431.9B $373.4B $263.1B $202.8B $182.1B $123.2B $113.7B $98.99B $86.12B $81.36B
YoY Change -85.93% 23.97% -17.38% -702.82% -147.61% -41.25% 51.52% 18.92% -182.88% -191.56% 22.47% -48.63% -32.05% -10.64% 4.34% -30.91% -7.76% 20.74% 17.42% -1.13% 3.3% 15.66% 41.95% 29.74% 11.32% 47.79% 8.38% 14.88% 14.95% 5.85%
Income Tax -$91.41B $58.05B $72.41B -$9.936B -$105.0B -$7.468B $30.50B $27.83B $37.06B -$2.403B $49.29B -$3.880B $125.2B $121.3B $115.7B $161.4B $218.8B $285.8B $201.4B $160.2B $157.9B $157.5B $134.9B $114.1B $81.45B $89.02B $63.17B $58.09B $49.24B $41.57B $41.99B
% Of Pretax Income -173.15% 15.48% 23.93% -2.71% -5.85% 14.04% 19.42% 30.74% 31.03% -2.99% 49.59% 32.65% 27.82% 40.48% 37.92% 45.71% 38.88% 36.32% 35.39% 36.46% 36.12% 43.39% 40.17% 48.87% 51.26% 51.09% 49.74% 48.27% 51.62%
Net Earnings $144.1B $317.0B $230.1B $376.0B $44.24B $135.2B $186.9B $114.9B $80.17B -$145.8B $106.7B $131.2B $124.2B $247.9B $297.7B $234.4B $355.5B $335.8B $313.2B $277.4B $285.3B $271.8B $235.7B $146.9B $119.6B $91.76B $82.59B $71.38B $59.85B $51.43B $47.63B
YoY Change -54.56% 37.8% -38.81% 749.9% -67.28% -27.66% 62.59% 43.38% -154.99% -236.67% -18.73% 5.7% -49.91% -16.75% 27.03% -34.06% 5.85% 7.2% 12.91% -2.74% 4.97% 15.32% 60.47% 22.76% 30.37% 11.1% 15.7% 19.28% 16.36% 7.98%
Net Earnings / Revenue 3.38% 7.87% 6.45% 11.76% 1.34% 6.45% 10.56% 6.64% 4.44% -8.2% 6.3% 8.43% 8.23% 17.46% 20.31% 15.24% 25.85% 25.73% 25.84% 24.71% 26.26% 25.98% 23.45% 15.24% 12.96% 10.86% 9.81% 8.51% 7.47% 6.66% 6.54%
Basic Earnings Per Share
Diluted Earnings Per Share $92.09 $201.90 $145.9M $239.0M $28.25M $139.8M $237.6M $146.3M $101.7M -$185.4M $135.0M $166.1M $157.2M $313.8M $377.4M $289.7M $419.2M $386.0M $354.0M $313.5M $322.3M $308.1M $266.9M $166.3M $135.5M $103.2M $93.21M $80.57M $67.62M $58.71M $54.44M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Cash & Short-Term Investments $472.9B $553.7B $875.0B $1003B $653.4B $725.8B $375.2B $376.1B $560.0B $713.4B $851.0B $547.7B $455.6B $874.2B $883.2B $758.8B $1685B $1800B $1857B $1522B $1323B $1166B $941.2B $723.4B $638.5B $540.8B $492.6B $435.9B $390.9B $351.8B $341.7B
YoY Change -14.6% -36.72% -12.75% 53.47% -9.97% 93.46% -0.25% -32.84% -21.5% -16.17% 55.38% 20.21% -47.88% -1.02% 16.4% -54.97% -6.39% -3.05% 21.97% 15.07% 13.41% 23.92% 30.1% 13.3% 18.06% 9.79% 13.0% 11.53% 11.1% 2.96%
Cash & Equivalents $457.8B $533.5B $389.1B $335.0B $188.6B $462.9B $243.3B $278.5B $437.9B $461.0B $353.2B $289.6B $214.9B $217.9B $266.5B $229.5B $239.5B $385.4B $450.7B $429.5B $473.0B $827.7B $587.1B $488.7B $368.6B $313.8B $399.8B $383.4B $351.4B $331.0B $326.9B
Short-Term Investments $15.09B $20.17B $485.9B $667.8B $464.8B $262.9B $131.9B $97.65B $122.1B $252.4B $497.9B $258.1B $240.7B $656.3B $616.7B $529.2B $1445B $1414B $1406B $1093B $849.8B $338.7B $354.1B $234.7B $269.9B $227.0B $92.85B $52.58B $39.41B $20.85B $14.79B
Other Short-Term Assets $178.2B $176.1B $141.1B $143.5B $271.5B $598.4B $61.89B $213.5B $129.2B $77.47B $44.51B $335.5B $286.5B $281.8B $272.3B $283.7B $195.4B $191.0B $180.8B $128.1B $105.3B $84.39B $73.70B $60.91B $48.40B $39.63B $48.52B $40.89B $36.17B $29.11B $27.85B
YoY Change 1.2% 24.81% -1.66% -47.15% -54.64% 866.99% -71.01% 65.24% 66.76% 74.03% -86.73% 17.08% 1.68% 3.5% -4.03% 45.2% 2.28% 5.65% 41.17% 21.63% 24.8% 14.5% 21.01% 25.85% 22.13% -18.33% 18.65% 13.08% 24.25% 4.52%
Inventory $1210B $986.5B $853.2B $753.9B $759.6B $919.7B $212.9B $226.0B $254.0B $262.4B $254.3B $229.5B $195.0B $137.1B $137.7B $131.7B $116.1B $105.3B $98.26B $94.57B $92.93B $89.49B $96.09B $100.4B $105.0B $107.8B $107.0B $102.0B $102.8B $99.20B $95.25B
Prepaid Expenses
Receivables $668.4B $649.4B $617.5B $707.5B $670.7B $657.7B $360.8B $356.5B $376.5B $400.8B $375.9B $342.4B $341.8B $293.1B $279.7B $301.4B $247.3B $261.4B $236.4B $225.1B $209.1B $201.9B $234.1B $254.2B $233.5B $225.7B $230.3B $248.6B $258.8B $242.7B $230.1B
Other Receivables $29.21B $32.26B $106.9B $105.2B $114.2B $91.44B $67.96B $88.33B $54.08B $65.98B $66.72B $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $2559B $2398B $2594B $2713B $2469B $2993B $1079B $1260B $1374B $1520B $1593B $1455B $1279B $1586B $1573B $1476B $2244B $2358B $2372B $1970B $1730B $1542B $1345B $1139B $1026B $914.0B $878.5B $827.5B $788.6B $722.8B $694.9B
YoY Change 6.7% -7.54% -4.4% 9.86% -17.49% 177.44% -14.41% -8.25% -9.62% -4.55% 9.45% 13.77% -19.37% 0.85% 6.59% -34.24% -4.83% -0.6% 20.41% 13.86% 12.19% 14.65% 18.1% 11.06% 12.21% 4.04% 6.17% 4.93% 9.1% 4.02%
Property, Plant & Equipment $1990B $1691B $1583B $1454B $1386B $1332B $536.8B $527.3B $551.9B $526.2B $542.3B $511.1B $488.7B $407.5B $318.9B $258.5B $236.1B $238.4B $215.7B $220.1B $230.5B $203.3B $213.4B $220.4B $240.5B $224.2B $232.1B $229.4B $231.5B $241.5B $210.2B
YoY Change 17.65% 6.85% 8.86% 4.87% 4.09% 148.12% 1.79% -4.45% 4.89% -2.97% 6.1% 4.58% 19.93% 27.76% 23.39% 9.47% -0.97% 10.56% -2.03% -4.51% 13.41% -4.74% -3.16% -8.39% 7.27% -3.39% 1.17% -0.92% -4.13% 14.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $430.6B $378.9B $330.1B $348.4B $369.5B $299.9B $304.4B $303.0B $186.2B $282.0B $234.9B $216.0B $226.0B $191.6B $204.4B $200.3B $297.2B $413.2B $400.6B $314.9B $360.4B $297.7B $394.1B $374.4B $152.7B $154.8B $155.3B $138.1B $122.7B $113.3B $115.7B
YoY Change 13.66% 14.76% -5.23% -5.71% 23.18% -1.47% 0.44% 62.76% -33.97% 20.04% 8.74% -4.44% 17.99% -6.29% 2.09% -32.61% -28.08% 3.16% 27.19% -12.62% 21.06% -24.45% 5.26% 145.14% -1.34% -0.31% 12.47% 12.54% 8.26% -2.04%
Other Assets $445.1B $429.3B $445.2B $454.1B $411.9B $176.5B $143.0B $173.4B $189.7B $206.7B $249.2B $82.63B $66.06B $83.31B $86.74B $77.77B $61.75B $52.08B $48.57B $30.74B $4.135B $3.165B $4.412B $5.011B $43.01B $28.34B $23.34B $22.90B $25.45B $20.73B $18.43B
YoY Change 3.67% -3.55% -1.97% 10.23% 133.45% 23.44% -17.55% -8.63% -8.2% -17.05% 201.57% 25.09% -20.71% -3.96% 11.54% 25.93% 18.57% 7.24% 57.98% 643.43% 30.65% -28.26% -11.95% -88.35% 51.75% 21.44% 1.94% -10.04% 22.77% 12.49%
Total Long-Term Assets $12550B $11560B $10580B $10200B $10350B $10800B $3028B $3086B $2450B $2776B $2977B $2501B $2298B $1200B $1250B $1285B $605.5B $714.8B $670.3B $575.5B $605.5B $517.2B $620.1B $608.8B $441.4B $413.7B $418.4B $394.5B $384.6B $388.9B $358.6B
YoY Change 8.57% 9.22% 3.77% -1.47% -4.15% 256.7% -1.9% 25.96% -11.74% -6.74% 19.04% 8.81% 91.48% -4.02% -2.66% 112.16% -15.29% 6.63% 16.47% -4.95% 17.08% -16.6% 1.86% 37.92% 6.69% -1.11% 6.06% 2.57% -1.11% 8.46%
Total Assets $15110B $13960B $13180B $12910B $12820B $13790B $4106B $4347B $3824B $4296B $4569B $3956B $3577B $2786B $2823B $2760B $2849B $3073B $3042B $2545B $2336B $2059B $1965B $1748B $1467B $1328B $1297B $1222B $1173B $1112B $1053B
YoY Change
Accounts Payable $547.5B $649.2B $295.9B $232.1B $211.6B $212.3B $133.7B $125.7B $135.2B $124.4B $129.3B $118.7B $102.0B $83.07B $72.82B $68.13B $72.47B $77.44B $78.20B $70.75B $73.19B $77.60B $89.00B $97.36B $115.5B $114.0B $111.4B $117.4B $115.6B $113.6B $105.3B
YoY Change -15.67% 119.39% 27.5% 9.68% -0.34% 58.82% 6.36% -7.02% 8.72% -3.85% 8.98% 16.42% 22.74% 14.07% 6.89% -5.99% -6.42% -0.97% 10.52% -3.34% -5.68% -12.8% -8.59% -15.68% 1.3% 2.34% -5.13% 1.57% 1.79% 7.81%
Accrued Expenses $218.4B $205.5B $157.5B $156.4B $130.5B $167.2B $147.0B $159.9B $132.3B $114.3B $99.06B $103.4B $32.02B $27.25B $22.45B $76.30B $71.65B $65.95B $56.14B $50.35B
YoY Change 6.32% 30.43% 0.69% 19.84% -21.94% 13.76% -8.06% 20.89% 15.69% 15.41% -4.22% 223.02% 17.5% 21.39% -70.58% 6.49% 8.65% 17.47% 11.5%
Deferred Revenue
YoY Change
Short-Term Debt $251.0M $256.0M $285.0M $69.00M $5.014B $500.0B $18.00M $405.1B $0.00 $0.00 $1.226B $1.795B $241.4B $1.332B $3.285B $3.214B $3.361B $4.961B $5.446B $8.301B $6.838B $4.672B $5.898B $8.674B $15.69B $10.99B $11.14B $13.97B $13.11B $11.54B $9.752B
YoY Change -1.95% -10.18% 313.04% -98.62% -99.0% 2777688.89% -100.0% -100.0% -31.7% -99.26% 18023.95% -59.45% 2.21% -4.37% -32.25% -8.91% -34.39% 21.4% 46.36% -20.79% -32.0% -44.71% 42.82% -1.36% -20.27% 6.51% 13.63% 18.34%
Long-Term Debt Due $367.3B $339.6B $203.7B $22.08B $581.8B $484.9B $140.0B $228.5B $154.2B $154.2B $13.00M $1.250B $0.00 $22.35B
YoY Change 8.14% 66.71% 822.42% -96.2% 19.97% -38.73% 48.18% 0.0% -98.96%
Total Short-Term Liabilities $2313B $2482B $2146B $1773B $2176B $2553B $737.5B $1366B $857.2B $1017B $802.8B $613.6B $751.7B $436.6B $428.5B $472.1B $428.7B $442.4B $488.2B $365.5B $370.6B $344.7B $371.8B $345.6B $314.7B $278.9B $323.4B $292.2B $298.2B $275.1B $272.4B
YoY Change -6.8% 15.67% 21.01% -18.51% -14.77% 246.17% -46.02% 59.39% -15.7% 26.67% 30.82% -18.37% 72.18% 1.9% -9.24% 10.12% -3.1% -9.39% 33.58% -1.37% 7.5% -7.28% 7.57% 9.81% 12.87% -13.77% 10.65% -2.0% 8.39% 0.98%
Long-Term Debt $4477B $4043B $4141B $4613B $4506B $4766B $985.6B $599.9B $539.8B $629.4B $704.6B $556.0B $317.9B $16.39B $15.53B $16.55B $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $29.38B $29.39B $29.39B $29.39B
YoY Change 10.73% -2.38% -10.23% 2.37% -5.45% 383.54% 64.31% 11.13% -14.24% -10.67% 26.72% 74.92% 1839.71% 5.5% -6.15% -100.0% -0.04% 0.0% 0.0%
Other Long-Term Liabilities $927.0B $783.2B $734.2B $772.2B $646.1B $504.4B $275.2B $278.2B $292.4B $287.6B $240.6B $240.5B $133.8B $84.47B $72.79B $76.00B $38.09B $44.29B $52.22B $58.19B $64.55B $70.33B $74.49B $89.34B $104.8B $111.8B $116.0B $116.6B $120.3B $129.5B $116.4B
YoY Change 18.36% 6.68% -4.92% 19.51% 28.11% 83.29% -1.1% -4.86% 1.67% 19.56% 0.05% 79.69% 58.42% 16.05% -4.22% 99.52% -14.0% -15.19% -10.26% -9.86% -8.21% -5.58% -16.62% -14.74% -6.24% -3.67% -0.54% -3.01% -7.14% 11.28%
Total Long-Term Liabilities $5404B $4826B $4876B $5385B $5153B $5270B $1261B $878.1B $832.2B $917.1B $945.2B $796.5B $451.7B $100.9B $88.32B $92.55B $38.09B $44.29B $52.22B $58.19B $64.55B $70.33B $74.49B $89.34B $104.8B $111.8B $116.0B $146.0B $149.7B $158.9B $145.8B
YoY Change 11.97% -1.02% -9.47% 4.52% -2.23% 318.01% 43.59% 5.51% -9.25% -2.97% 18.67% 76.34% 347.85% 14.19% -4.57% 142.98% -14.0% -15.19% -10.26% -9.86% -8.21% -5.58% -16.62% -14.74% -6.24% -3.67% -20.56% -2.42% -5.82% 9.01%
Total Liabilities $7836B $7604B $7495B $7739B $8098B $8611B $2109B $2453B $1875B $2159B $2098B $1796B $1565B $694.5B $701.9B $748.7B $568.5B $652.3B $693.9B $544.0B $554.7B $491.6B $545.1B $534.9B $457.7B $420.5B $467.6B $464.8B $473.3B $458.7B $439.6B
YoY Change 3.05% 1.45% -3.16% -4.43% -5.96% 308.28% -14.01% 30.77% -13.14% 2.89% 16.86% 14.76% 125.3% -1.06% -6.25% 31.71% -12.84% -6.0% 27.54% -1.92% 12.82% -9.81% 1.91% 16.88% 8.85% -10.07% 0.58% -1.79% 3.19% 4.34%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $6.7547 Trillion

About TAKEDA PHARMACEUTICAL CO LTD

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 49,281 full-time employees. The firm is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The firm's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The firm is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Industry: Pharmaceutical Preparations Peers: